Paper39769334
Targeting Cancer: Microenvironment and Immunotherapy Innovations.
Padzińska-Pruszyńska IB and 9 others. Int J Mol Sci, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Targeting Cancer: Microenvironment and Immunotherapy Innovations. Papers, record 39769334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39769334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Lymphocytes, Tumor-Infiltrating | |
| Animals |
Source PubMed
References236
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18835032 | Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18835032 | PubMed |
| 2 | 32395366 | NK Cell-Based Immunotherapies in Cancer. | Immune Netw | 2020 | https://conductscience.org/library/papers/32395366 | PubMed |
| 3 | 31350295 | The Tumor Microenvironment Innately Modulates Cancer Progression. | Cancer Res | 2019 | https://conductscience.org/library/papers/31350295 | PubMed |
| 4 | 1382544 | Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophils. | Br J Haematol | 1992 | https://conductscience.org/library/papers/1382544 | PubMed |
| 5 | 37394578 | Cancer-associated fibroblasts: from basic science to anticancer therapy. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37394578 | PubMed |
| 6 | 20226531 | A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. | Mol Immunol | 2010 | https://conductscience.org/library/papers/20226531 | PubMed |
| 7 | 31500313 | Vascular Endothelial Cell Biology: An Update. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31500313 | PubMed |
| 8 | 36706760 | Neutrophil-activating therapy for the treatment of cancer. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36706760 | PubMed |
| 9 | 10365666 | Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. | Hum Gene Ther | 1999 | https://conductscience.org/library/papers/10365666 | PubMed |
| 10 | 11106265 | Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/11106265 | PubMed |
| 11 | 19432918 | Prognostic implications of circulating anti-p53 antibodies in lung cancer--a review. | Eur J Cancer Care (Engl) | 2009 | https://conductscience.org/library/papers/19432918 | PubMed |
| 12 | 17974953 | Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. | Cancer Res | 2007 | https://conductscience.org/library/papers/17974953 | PubMed |
| 13 | 24475900 | Tumor infiltrating B-cells are increased in prostate cancer tissue. | J Transl Med | 2014 | https://conductscience.org/library/papers/24475900 | PubMed |
| 14 | 10947988 | Genes expressed in human tumor endothelium. | Science | 2000 | https://conductscience.org/library/papers/10947988 | PubMed |
| 15 | 15894262 | De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. | Cancer Cell | 2005 | https://conductscience.org/library/papers/15894262 | PubMed |
| 16 | 39604727 | Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. | Nature | 2025 | https://conductscience.org/library/papers/39604727 | PubMed |
| 17 | 1534242 | The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. | Annu Rev Immunol | 1992 | https://conductscience.org/library/papers/1534242 | PubMed |
| 18 | 28504320 | Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration. | Adv Mater | 2017 | https://conductscience.org/library/papers/28504320 | PubMed |
| 19 | 15800326 | Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15800326 | PubMed |
| 20 | 23499742 | B cells and their mediators as targets for therapy in solid tumors. | Exp Cell Res | 2013 | https://conductscience.org/library/papers/23499742 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42753002 | Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42753002 | PubMed |
| 42690554 | Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42690554 | PubMed |
| 42630543 | Pediatric leukemia: origins, pathogenesis, the role of microenvironment and immunological modulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42630543 | PubMed |
| 41376222 | Wenshen Zhuanggu Fang reduces breast cancer bone metastasis by regulating macrophage polarization: a bioinformatics analysis combined with experimental validation. | J Tradit Chin Med | 2025 | https://conductscience.org/library/papers/41376222 | PubMed |
| 41230088 | PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41230088 | PubMed |
| 41097709 | Macrophages-Target and Tool in Tumor Treatment: Insights from Ovarian Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097709 | PubMed |
| 40467942 | Advancing the potential of nanoparticles for cancer detection and precision therapeutics. | Med Oncol | 2025 | https://conductscience.org/library/papers/40467942 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39769334
GET https://conductscience.org/api/papers/v1/39769334/references?page=2